UK Medical Device Registration Cost 2026: UKRP Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
How much does it cost to register a medical device in the UK in 2026? A buyer-side breakdown of UK Responsible Person (UKRP) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios that incorporate the new MHRA annual GMDN-category fee from April 2026.
How Much Does It Cost to Register a Medical Device in the UK in 2026?
For a single foreign-manufactured device entering Great Britain in 2026, expect a 3-year all-in budget of roughly USD 7,500–18,000 for a Class I or IIa device and USD 9,000–32,000 for a Class IIb or III device, excluding MHRA government fees, UK Approved Body conformity assessment fees, English-language labeling rework, and UK-specific clinical evidence. As of 1 April 2026, every line compounds against a new MHRA annual fee of GBP 300 per GMDN Level 2 category — a fundamental change from the previous one-off DORS fee, and the single biggest reason UK Responsible Person pricing structure now matters more than six months ago.
The wide range is driven almost entirely by how your UK Responsible Person (UKRP) bills you.
Three pricing models dominate the UKRP market today, and the difference between the cheapest and most expensive can exceed 4x over three years for the same scope of work:
| UKRP Pricing Model | Year 1 Cost (Class I/IIa, 1 device) | Year 1 Cost (Class IIb/III, 1 device) | 3-Year Total (Class I/IIa) | 3-Year Total (Class IIb/III) |
|---|---|---|---|---|
| Hourly billing | $5,000–$9,500 | $11,000–$22,000 | $11,000–$18,000 | $25,000–$40,000 |
| Registration fee + lower annual | $3,000–$6,500 | $5,500–$11,000 | $7,500–$15,000 | $14,000–$26,000 |
| Flat all-inclusive annual fee | $2,000–$3,000 | $2,000–$3,000 | $6,000–$9,000 | $6,000–$9,000 |
The new annual MHRA fee (GBP 300/category) plus the UKRP service fee together form the recurring UK compliance cost. That recurrence is the new reality — and flat-fee UKRP pricing is the only model that does not multiply your exposure to it.
Skip to Your Scenario
- Single Class I or IIa device, pre-revenue startup: Read Scenario A first — flat fee saves $6,000+ in Year 1 cash.
- Single Class IIb or III device entering Great Britain: Read Scenario B — Year 1 burden under hourly is over 60% of 3-year cost.
- Multi-device portfolio (3+ devices): Read Scenario C — UKRP tier discounts plus GMDN-category aggregation compound dramatically.
- Already have a UKRP and want to switch: Skip to the UKRP Switching Playbook.
- Issuing an RFP this week: Skip to the RFP Template and 8 questions to ask.
- Want to validate the numbers: Read the Named Provider RFP Comparison.
Why UKRP Pricing Is Where UK Budgets Win or Lose
Great Britain requires every non-UK manufacturer to appoint a UK Responsible Person — a UK-established legal entity that holds the manufacturer's MHRA registration, maintains a copy of the technical documentation, acts as the MHRA's correspondence point for vigilance and PMS, signs DORS submissions, manages registration variations, and handles the new annual GMDN-category fee payments. The requirement was introduced through the Medical Devices (Amendment) (Great Britain) Regulations 2023 and is fully in force.
The UKRP is not optional for non-UK manufacturers. It is also not a one-time engagement. The relationship runs for as long as your device is sold in Great Britain, which under indefinite CE recognition can effectively be indefinite. Small differences in pricing model compound enormously over device life.
UK regulatory churn between 2023 and 2026 is the highest of any major market in the world per square inch of legislation:
- New annual MHRA fee (1 April 2026) — GBP 300 per GMDN Level 2 category, replacing the prior one-off DORS registration fee. Non-payment within 90 days triggers DORS account suspension and loss of GB market access.
- DORS portfolio cleanse deadline (30 March 2026) — manufacturers were required to verify and deregister obsolete devices before the fee transition.
- UK MDR 2002 amendment regulations (SI 2026/197) — implementing the new fee structure.
- Post-Market Surveillance regulations (June 2025) — mandatory PMSR/PSUR, 15-day serious incident reporting, MORE portal schemas refreshed October 2025.
- Indefinite CE recognition consultation (Feb–Apr 2026) — will likely trigger registration data updates.
- Pre-market Statutory Instrument (expected late 2026) — International Recognition Framework, GSPR-aligned essential requirements, UDI, IVD risk-based classification.
- Cybersecurity guidance for connected medical devices — emerging MHRA expectations.
Every one of those changes is an event that hits your DORS records and either generates UKRP work or does not — depending on what your contract calls "included."
The catch: most UKRP pricing is not published. You issue an RFP, sign an NDA, and compare proposals where every firm has a different scope inclusion list. That is the comparison this article is designed to short-circuit.
The Three UKRP Pricing Models, Decoded
Model 1: Hourly billing ("charge by hour")
The default model for small-to-mid regulatory firms in the UK and the historical industry standard. Scope is captured in a Statement of Work; everything outside scope is billed at hourly rates that typically run $135–$400/hour depending on tier:
| Consultant Tier | UK Hourly Rate (2026) | Typical Work |
|---|---|---|
| Tier 1 — senior regulatory strategist / former MHRA | $340–$400/hr | UKCA strategy, MHRA escalations, AI Airlock interface, IVD framework transition planning |
| Tier 2 — regulatory specialist | $250–$300/hr | DORS submissions, GMDN coding, PMS plan, vigilance correspondence |
| Tier 3 — associate / documentation | $135–$175/hr | Free-sale certificate requests, label review, English-language QC, fee administration |
(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region.)
Why buyers choose hourly: flexibility, perceived control, ability to use the UKRP only when needed.
Why hourly fails buyers in practice:
- No incentive to be efficient. Every hour the UKRP spends is revenue. No economic reason to optimize a process or reuse a template.
- Surprise invoices. A "quick check on a DORS update" becomes 4 hours. PSUR review becomes 8 hours.
- Scope creep is invisible until it bills. A variation triggered by a CE certificate refresh can be 2 hours or 12 — you find out after.
- Year 1 cash flow shock. First-year work (initial DORS registration, GMDN code mapping, English label QC, MORE portal setup) is frequently 3–5x steady-state annual hours.
- Annual MHRA fee management is a billable touch-point. Under hourly, the annual GBP 300/category fee triggers a billable interaction every year that flat-fee buyers do not pay for.
A typical Class IIb hourly engagement runs $11,000–$22,000 in Year 1 and $3,000–$8,000/year thereafter.
Model 2: Registration fee + lower annual maintenance
The dominant model for mid-to-large UKRP service firms today. Buyer pays a one-time setup/registration fee plus a smaller recurring annual fee. Scope is bundled but each "extra" is an itemized add-on.
Typical structure:
| Component | Class I/IIa | Class IIb/III |
|---|---|---|
| One-time setup fee | $1,000–$2,500 | $2,000–$4,500 |
| Initial DORS registration filing | $1,500–$3,500 | $3,000–$7,000 |
| Annual maintenance fee | $1,200–$2,500 | $2,500–$5,000 |
| Per-variation fee (DORS update) | $300–$1,200 | $750–$3,000 |
| Per-free-sale-certificate request | $150–$400 | $150–$400 |
| Vigilance/PMS forwarding (per event) | included or $200–$500 each | $300–$800 each |
| Annual MHRA fee administration | included or $100–$300 | included or $100–$300 |
| PSUR/PMSR review (Class IIa+) | not always included | $750–$2,500 each cycle |
The trap: the marketing message is "low annual fee," but Year 1 actual spend is usually $3,000–$11,000 because every registration triggers setup + filing + GMDN mapping + vigilance setup simultaneously. In subsequent years, every regulatory event is itemized.
Where this model fails buyers:
- Year 1 cash flow shock is structural. All major one-time fees fire in the same year you have not yet started selling.
- Variations are unbounded. UK churn (June 2025 PMS overhaul, October 2025 MORE schema update, February 2026 DORS PARD launch, April 2026 fee transition, expected late-2026 pre-market SI) generates 2–5 DORS variations per device per year. At $750/each that is a $1,500–$4,000/year invisible tax.
- Free-sale certificates scale with export expansion. At $150–$400 each, a manufacturer expanding to 5 markets pays $750–$2,000/year in administrative letters.
- PSUR/PMSR are statutory since 16 June 2025. Reg-plus-annual contracts often quote PSUR review separately at $750–$2,500 per cycle per device.
- Annual MHRA fee admin compounds. A UKRP that charges $200 to "administer" each annual category fee adds $400–$1,200/year per multi-category portfolio.
Model 3: Flat all-inclusive annual fee
A newer pricing model where the UKRP charges a single annual fee that includes the initial DORS registration, all variations, all free-sale certificate requests, all vigilance/PMS forwarding, all MHRA correspondence, the annual fee administration, and renewals. The same number every year, year 1 to year N.
This model has two structural advantages:
- The fee curve is flat instead of front-loaded. Year 1 cost equals Year 2 cost equals Year 3 cost. The pre-revenue period is no longer cash-flow-hostile.
- The UKRP's incentives align with yours. Once you sign, every additional hour the UKRP spends is pure cost to them. They are economically motivated to be efficient, file cleanly, and avoid MHRA back-and-forth.
The catch: flat-fee UKRPs typically require a multi-year contract (so the firm can amortize Year 1 work) and exclude government fees, the new annual MHRA GMDN-category fees, UK Approved Body conformity assessment fees, and clinical evidence preparation.
This model is also rare. As of April 2026, Pure Global is the only major UKRP service provider that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing), which makes it the only published reference point for buyers comparing models.
Why this guide uses Pure Global as the worked example
We use Pure Global's published UKRP rates throughout because they are the only flat-fee UKRP rates in the public domain — verifiable at pureglobal.com/services/pricing. This is not an endorsement. Published rates simply enable apples-to-apples cash flow comparison that would otherwise require RFPs under NDA. Hourly and front-loaded ranges are drawn from typical RFP responses, published consulting hourly benchmarks, and procurement data collected by MedDeviceGuide.
Pure Global UK UKRP Pricing (Published, April 2026)
Single Tier Schedule — All Classes (MD and IVD)
Unlike Brazil or Mexico, where pricing splits by risk class because the underlying regulatory work scales with class, the UK's UKRP role is statutorily the same regardless of device class. The variable that drives Pure Global's UK pricing is therefore portfolio size — the number of registrations held by the manufacturer.
| Number of Registrations | Annual Flat Fee (USD) |
|---|---|
| 1 | $2,000 |
| 2 | $2,500 |
| 3 | $3,000 |
| 4 | $3,500 |
| 5 | $4,000 |
| 6+ | Custom quote |
Included in the annual fee — per Pure Global's published price list ("preparation and submission of the registration, modifications, renewals, free sale certificate requests, and correspondence with authorities. Based on CE reference market approval"):
- Preparation and submission of the DORS registration based on a CE reference market approval (the manufacturer supplies the CE certificate and the underlying technical documentation; Pure Global handles the DORS filing itself)
- Modifications to the registration — DORS variations such as labeling-driven updates, importer/distributor changes, GMDN-code corrections, and CE-certificate-refresh updates
- Registration renewals
- Free-sale certificate requests through MHRA on the registered devices
- Correspondence with MHRA on the registered devices
Inherent to the UK Responsible Person statutory role under UK MDR 2002 (as amended by SI 2019/791 and SI 2023/627), Regulation 19A and Schedule 2A (included by definition, not separately billable):
- Holding the manufacturer's MHRA registration and acting as the registered UKRP on DORS
- Maintaining a copy of the technical documentation so it can be made available to MHRA on request
- Forwarding MHRA queries, vigilance notifications, and FSCAs between MHRA and the manufacturer (Pure Global routes communications; preparing the manufacturer's incident analysis or PSUR/PMSR content is not in scope)
- Cooperating with MHRA on PMS and post-market actions taken in respect of the registered devices
Confirm scope before signing — these activities are not itemized on Pure Global's published price list, so verify in writing whether they sit inside the annual fee or are quoted separately:
- Administration of the annual GBP 300/GMDN Level 2 category fee — whether Pure Global processes the DORS payment as part of the flat fee or treats it as a separately billable touch-point (the underlying GBP 300 government fee is in any case passed through to the manufacturer at cost — confirm no markup)
- MORE portal account setup and integration for vigilance/FSCA reporting
- DORS account suspension recovery if a fee deadline is missed
- English-language QC of submission documents (separate from IFU translation, which is excluded)
- UK Approved Body conformity assessment liaison beyond routine MHRA correspondence
- Bulk GMDN Level 2 mapping for very large portfolios at onboarding (typically scoped as a one-time project under any vendor)
Not included — separately quoted on Pure Global's consulting menu or excluded entirely (UK is a representative-only market — dossier preparation is not included in the flat fee):
- UK technical documentation authoring or compilation — the UKRP holds a copy and verifies completeness; the manufacturer prepares the file
- PSUR / PMSR authoring — Pure Global forwards manufacturer-prepared PSURs to MHRA on request; preparing the document is the manufacturer's obligation
- UK-specific clinical evidence preparation
- English-language translation of original IFU/labeling content
- Ad-hoc consulting / out-of-scope work at $200/hour (see contract terms below)
Government / Approved-Body pass-through (no markup): MHRA annual fee (GBP 300 per GMDN Level 2 category, effective 1 April 2026) is passed through at cost. UK Approved Body conformity assessment fees, clinical investigation application fees (GBP 2,000–8,000), and any MHRA regulatory advice meeting fees are paid directly by the manufacturer or passed through at cost.
Contract Terms
- Standard contract: 3 years.
- Annual contract option: available, but the first-year fee is increased by 50%.
- Early termination: allowed at any time with a 50% payoff of the remaining contract value.
- Ad-hoc consulting (non-clients or out-of-scope work): $200/hour.
(Source: pureglobal.com/services/pricing, captured April 2026. Price list version 2.0, last updated 2026-04-08.)
3-Year Cash Flow: Side-by-Side Comparison
The pricing model only matters because of cash timing. The following scenarios show the same scope of work — one device, UKRP only, MHRA government fees called out separately — under each of the three models. Numbers are illustrative and based on the ranges given above.
Scope assumption. The Pure Global flat-fee column in these scenarios assumes that routine annual-MHRA-fee administration, MORE portal setup, and English-language QC for contracted device groups are inside the published flat fee, consistent with typical full-service UKRP practice. Pure Global's published price list itemizes only "preparation and submission of the registration, modifications, renewals, free sale certificate requests, and correspondence with authorities" — the items above are not separately itemized, so confirm in writing before signing. The underlying GBP 300/category MHRA government fee is in any case passed through at cost. Bulk GMDN Level 2 mapping or English-language QC for very large portfolios is typically a separate one-time onboarding project under any vendor.
Scenario A: Single Class I/IIa Device, 3-Year Total
Scope baseline: 1 Class IIa medical device, CE-marked under EU MDR, GB market entry under indefinite CE recognition, 1 GMDN Level 2 category, average 3 DORS variations per year (consistent with 2025–2026 UK regulatory churn), 4 free-sale certificate requests over 3 years.
| Cost Bucket | Hourly Billing | Registration + Annual | Flat Fee (Pure Global) |
|---|---|---|---|
| Year 1 setup + initial DORS filing | $5,500 (28 hrs × $200 blended) | $3,500 ($1,500 setup + $2,000 filing) | $2,000 |
| Year 1 variations + free-sale certs | $1,500 (8 hrs) | $1,200 (3 vars × $400) | included |
| Year 1 annual MHRA fee admin | $200 (1 hr T2) | $200 | included |
| Year 1 UKRP total (excl govt fees) | $7,200 | $4,900 | $2,000 |
| Year 1 MHRA govt fee (1 GMDN cat × GBP 300) | ~$380 | ~$380 | ~$380 |
| Year 2 maintenance | $2,800 (14 hrs) | $1,800 annual + $1,200 vars | $2,000 |
| Year 2 MHRA govt fee | ~$380 | ~$380 | ~$380 |
| Year 3 maintenance | $2,800 (14 hrs) | $1,800 annual + $1,200 vars | $2,000 |
| Year 3 MHRA govt fee | ~$380 | ~$380 | ~$380 |
| 3-Year UKRP Total | $12,800 | $10,900 | $6,000 |
| 3-Year MHRA Fee Total | $1,140 | $1,140 | $1,140 |
| 3-Year Grand Total | $13,940 | $12,040 | $7,140 |
| Year 1 share of 3-year UKRP spend | 56% | 45% | 33% |
The Year 1 burden under flat fee is $2,000 vs $7,200 under hourly — for the same regulatory output. That $5,200 of cash that does not leave the company in Year 1 is, for an early-stage MedTech, often the difference between launching in Great Britain this fiscal year and deferring 12–18 months. The new annual MHRA fee is identical in all three columns; the structural variance is entirely in the UKRP service line.
Scenario B: Single Class IIb/III Device, 3-Year Total
Scope baseline: 1 Class IIb medical device, CE-marked under EU MDR, GB market entry, 1 GMDN Level 2 category, average 4 DORS variations per year, statutory PSUR cycle (Class IIb = annual PSUR), 6 free-sale certificate requests over 3 years.
| Cost Bucket | Hourly Billing | Registration + Annual | Flat Fee (Pure Global) |
|---|---|---|---|
| Year 1 setup + initial DORS filing | $11,000 (50 hrs × $220 blended) | $7,000 ($3,000 setup + $4,000 filing) | $2,000 |
| Year 1 PSUR review/forwarding | $1,800 | $1,500 | included (forwarding only) |
| Year 1 variations + vigilance setup | $3,000 | $2,000 | included |
| Year 1 annual MHRA fee admin | $200 | $200 | included |
| Year 1 UKRP total (excl govt fees) | $16,000 | $10,700 | $2,000 |
| Year 2 maintenance | $5,500 (25 hrs) | $3,500 annual + $2,500 vars + $1,500 PSUR | $2,000 |
| Year 3 maintenance | $5,500 (25 hrs) | $3,500 annual + $2,500 vars + $1,500 PSUR | $2,000 |
| 3-Year UKRP Total | $27,000 | $22,200 | $6,000 |
| Year 1 share of 3-year UKRP spend | 59% | 48% | 33% |
Under hourly, 59% of the 3-year UKRP cost lands in Year 1 — the worst possible time for a UK entrant who has not yet earned UK NHS-channel revenue. Flat fee distributes the same scope of work evenly, freeing roughly $14,000 of Year 1 working capital for UK Approved Body fees, English labeling rework, NHS Supply Chain registration, or commercial hires.
Scenario C: 5-Device Portfolio, Mixed Classes
Scope baseline: 5 devices total (3 Class IIa, 2 Class IIb), all CE-marked, falling across 2 GMDN Level 2 categories. This is the realistic profile for a mid-size diagnostics or surgical-tool manufacturer entering the UK.
| Cost Bucket | Hourly Billing | Registration + Annual | Flat Fee (Pure Global) |
|---|---|---|---|
| Year 1 UKRP total | $35,000–$55,000 | $22,000–$38,000 | $4,000 |
| Year 2 UKRP | $14,000–$22,000 | $11,000–$18,000 | $4,000 |
| Year 3 UKRP | $14,000–$22,000 | $11,000–$18,000 | $4,000 |
| 3-Year UKRP Total | $63,000–$99,000 | $44,000–$74,000 | $12,000 |
| 3-Year MHRA govt fee (2 categories) | ~$2,280 | ~$2,280 | ~$2,280 |
For multi-device portfolios, the flat-fee tier curve (each additional registration is +$500/year incremental, not multiplicative) compounds the savings. A 5-device portfolio at Pure Global's published rates costs roughly one-fifth of the composite hourly midpoint. Even for buyers who would not otherwise consider flat fee, the cross-over for portfolios of 3+ devices is essentially automatic.
What "All-Inclusive" Actually Means: Scope Checklist
When UKRP proposals all claim to "include everything," the differences are in the fine print. Use this checklist to compare proposals line by line.
| Service Item | Hourly (typical) | Reg + Annual (typical) | Flat Fee — Pure Global |
|---|---|---|---|
| Initial DORS registration filing | hourly | one-time setup fee | included (published) |
| GMDN Level 2 category mapping & verification | hourly | sometimes included | confirm with provider (bulk mapping for large portfolios typically a separate one-time project) |
| English-language QC of submission documents | hourly | sometimes included, sometimes per-page | confirm with provider |
| Free-sale certificate requests via MHRA | hourly per request | $150–$400 each | included (published) |
| Registration variations (DORS updates / "modifications") | hourly per variation | $300–$3,000 each | included (published — "modifications") |
| MHRA correspondence and query response | hourly | hourly above contract scope | included (published — "correspondence with authorities") |
| Vigilance / FSCA / trend report forwarding via MORE | hourly | hourly or per-event | inherent to UKRP statutory role (UK MDR 2002 Reg 44A / Schedule 2A) |
| PSUR/PMSR forwarding to MHRA on request | hourly | hourly or per-event | inherent to UKRP statutory role (forwarding only) |
| PSUR/PMSR authoring (manufacturer's obligation) | hourly | hourly | not included — manufacturer's responsibility |
| Annual MHRA GBP 300/category fee administration | hourly | $100–$300 admin fee | confirm with provider (not itemized on published price list) |
| Annual MHRA GBP 300/category fee (passed through) | at cost | at cost | passed through at cost (no markup) |
| MORE portal account setup and integration | hourly | sometimes included | confirm with provider |
| DORS account suspension recovery (if fee missed) | hourly + risk | hourly + risk | confirm with provider |
| Holding a copy of technical documentation for MHRA on request | inherent to role | inherent to role | inherent to UKRP statutory role (UK MDR 2002 Schedule 2A) |
| Northern Ireland Authorised Representative role (if needed) | separate scope | separate scope | separate scope (not in UKRP fee) |
| English-language IFU translation | not in UKRP scope | not in UKRP scope | not included |
| UK technical documentation authoring/compilation | hourly | hourly | not included (UK is a representative-only market — dossier preparation is the manufacturer's job) |
| UK Approved Body conformity assessment liaison | hourly | hourly | confirm with provider (routine MHRA correspondence is included; complex AB-liaison work may be ad-hoc at $200/hour) |
| Clinical investigation application support | hourly | hourly | separate — $200/hour ad-hoc (consulting menu) |
| Out-of-scope ad-hoc consulting | $135–$400/hour | hourly | separate — $200/hour (consulting menu) |
The scope items that quietly drive Year-2-and-beyond cost overruns under the hourly and reg-plus-annual models are: variations, MHRA correspondence on PMS, free-sale certs, and annual fee administration. Together they generally account for 50–70% of post-Year-1 UKRP spend. Whether they are inside or outside the flat fee is the single biggest line in any side-by-side comparison.
What 2026 UK Regulatory Churn Costs Under Each Pricing Model
The UK has been the single most legislatively active major medical device market between 2023 and 2026. Each rule change forces existing registrations to file DORS variations, generate MORE schema-compliant reports, repackage technical files, or update labeling. Under hourly billing or reg-plus-annual, every one of those filings is a billable event. Under flat fee, they are not. This is the line item that competitors do not bring up during the sales call, and it is where the case for flat fee gets quantitatively compelling.
Variation Volume from 2023–2026 UK Rules
The cumulative variation/filing load a typical CE-marked device on the GB market has absorbed in the three years since the UKRP requirement came fully into force:
| Regulation / Event | Effective | DORS / Filing Action | Filings per Device |
|---|---|---|---|
| MD (Amendment) (GB) Regs 2023 | Late 2023 | Initial UKRP appointment, DORS registration | 1 |
| MD (Amendment) (GB) Regs 2024 | 2024 | Registration data updates, CE certificate refresh | 1 |
| PMS Regulations 2024 (SI 2024/1368) | 16 June 2025 | PMS plan reference, MORE integration, PSUR setup | 1–2 |
| MORE schema refresh | 16 October 2025 | XSD updates, IMDRF Annex codes, expanded UDI fields | 1 |
| PARD public access launch | 23 February 2026 | Brand/trade name verification | 1 |
| DORS portfolio cleanse | 30 March 2026 | Obsolete-device deregistration, GMDN corrections | 1–3 |
| Annual fee transition (SI 2026/197) | 1 April 2026 | GMDN Level 2 category confirmation | 1 |
| Periodic labeling/IFU updates | Ongoing | UKRP details, importer details, English QC | 1–2/year |
A typical Class IIa device has filed 6–10 cumulative DORS actions since the UKRP requirement came in. Class IIb/III devices, with PSUR cycles and higher-stakes vigilance, are closer to 8–14 filings.
What That Variation Volume Costs You
| Pricing Model | Per-Filing Cost | 3-Year Cost (Class IIa, 8 filings) | 3-Year Cost (Class IIb, 12 filings) |
|---|---|---|---|
| Hourly billing (3–6 hrs × $250 blended) | $750–$1,500 | $6,000–$12,000 | $9,000–$18,000 |
| Reg fee + annual ($300–$3,000 each) | $300–$3,000 | $2,400–$24,000 | $3,600–$36,000 |
| Pure Global flat fee | included | $0 incremental | $0 incremental |
Under hourly or reg-plus-annual, regulatory churn becomes a hidden tax that scales with how active the regulator is — not with how active you are. The MHRA is currently the most active medical device regulator in the world by volume of recent and pending changes. That is exactly the wrong environment in which to sign a 3-year hourly contract.
What MHRA Has Queued for 2026–2028
The pipeline already in consultation or scheduled, each triggering fresh filings:
- Indefinite CE recognition legislation (mid–late 2026): DORS registration data refresh.
- Pre-market Statutory Instrument (late 2026): International Recognition Framework, GSPR-aligned essential requirements, UDI, IVD risk-based classification — every existing registration gets touched.
- National AI Commission recommendations (2026) → SaMD framework reform (2027): likely up-classification of SaMD devices.
- Northern Ireland registration changes (28 May 2026): separate Authorised Rep overlay if you sell in NI.
- Annual MHRA fee escalation: GBP 300 is the launch rate; HM Treasury "Managing Public Money" guidance allows inflation-linked uplifts.
- Cybersecurity guidance for connected devices: likely to trigger labeling, IFU, and PMS plan amendments.
A reasonable 2026–2028 forecast for an existing Class IIb device is 5–8 additional DORS variations. At hourly rates that is another $4,000–$12,000 per device. Under flat fee, $0.
For a 5-device Class IIb portfolio, the difference between "variations included" and "variations billable" over 2026–2028 is roughly $20,000–$60,000 in net UK P&L impact — same regulatory work, same outcome, just different invoice line.
The Annual MHRA Fee Multiplies Everything
Before 1 April 2026, the MHRA's one-off DORS registration fee (GBP 261) was a fixed Year 1 cost. After 1 April 2026, GBP 300 annual per GMDN Level 2 category turns the fee itself into a recurring liability. Two consequences:
Recurring administrative touch-point. Every year by 30 June, the fee must be paid via DORS or the account suspends. Under hourly, that is a billable annual touch. Under reg-plus-annual, some firms charge $100–$300 administration. Under Pure Global's flat fee, it is included.
Multi-category manufacturers pay multiplicatively. A manufacturer with devices spanning 5 GMDN Level 2 categories pays GBP 1,500/year in MHRA fees alone — and every one is a UKRP touch-point under non-flat models.
The April 2026 transition makes UKRP pricing structure more consequential than at any time since the role was introduced.
When Flat Fee Wins, and When It Does Not
Flat fee usually wins when:
- You expect to keep the device on the GB market for ≥3 years (under indefinite CE recognition, essentially every device).
- You have ≥2 devices in your UK portfolio (tier discounts compound).
- Your devices are commercially active — ongoing variations, distributor changes, vigilance, labeling updates.
- Your devices span multiple GMDN Level 2 categories (annual fee admin overhead grows under non-flat models).
- You are pre-revenue or capital-constrained in Year 1.
- You want predictable cost projections against an actively-evolving regulatory baseline.
Hourly might still win when:
- One-time discovery exercise (e.g., UK feasibility under the proposed IRF) without a registration to maintain.
- Single very simple Class I device expected to file once and never modify.
- Ad-hoc strategic counsel (AI Airlock application, MHRA pre-submission meeting) outside an existing UKRP relationship.
Registration-fee-plus-annual is rarely optimal on TCO grounds. It lands between hourly and flat fee on cost while preserving Year 1 front-loading and per-event exposure to UK variation volume.
Government Fees: A Quick Reference
UKRP service fees are excluded from MHRA government fees in every model. For completeness, the official UK government fees for 2026 are:
| Filing | Government Fee | Frequency | Notes |
|---|---|---|---|
| DORS one-off device registration (until 31 March 2026) | GBP 261 | One-time | Replaced by annual fee from 1 April 2026 |
| Annual MHRA registration fee (from 1 April 2026) | GBP 300 per GMDN Level 2 category | Annual | Charged for financial year 1 April – 31 March; payment due within 90 days |
| Clinical investigation application (Class III / implantable) | GBP 4,000–8,000 | Per application | |
| Clinical investigation application (other devices) | GBP 2,000–4,000 | Per application | |
| MHRA regulatory advice meeting | See MHRA fees page | Per meeting | |
| UK Approved Body conformity assessment | Tens of thousands to hundreds of thousands | Per assessment | Separate from MHRA fees; varies by AB and device |
For the complete UK regulatory framework, transition timelines, and detailed fee guidance, see UK Medical Device Regulation Post-Brexit: UKCA Marking, MHRA & The Complete Guide.
8 Questions to Ask Any UKRP Before You Sign
Demand explicit, written answers before signing — not verbal assurances.
- Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (UK CPI? RPI? uncapped?). A UKRP that pegs its fee to government-fee growth is a red flag.
- How many DORS variations are included per year? "Unlimited" should be in writing. "Reasonable use" is a red flag. Ask specifically about CE-certificate refreshes and GMDN reclassifications.
- How many free-sale certificate requests are included per year? Manufacturers expanding to LATAM/MENA need 4–10 per year; reg-plus-annual contracts often charge $150–$400 each.
- Does the UKRP administer the annual MHRA fee, and is that billable? Some firms separate "fee management" as a chargeable line item.
- What is the per-hour rate for out-of-scope work? Some firms advertise low base fees and charge $400+/hour for anything outside scope.
- Who pays if the MHRA issues a query? Under hourly, you do. Under flat fee, the UKRP should. Confirm in writing.
- What are the termination terms? Pure Global publishes 50% payoff. Many competitors require full payoff or 12-month notice.
- Will the UKRP provide a transfer letter at no cost? Get the transfer-out commitment in writing — and ask how it interacts with the annual fee cycle.
If a UKRP refuses to answer any of these in writing, that is the answer.
UKRP Switching Playbook: How to Leave Without Getting Trapped
The single most expensive mistake in UKRP selection is signing a contract you cannot exit affordably. Many foreign manufacturers discover, 12–18 months in, that their UKRP is mediocre but switching costs more than staying. This section is the operational playbook competitors avoid publishing.
The MHRA UKRP Change Procedure
The MHRA permits change of UKRP via DORS without re-registering the device. The mechanic:
| Step | Who Performs | Typical Duration | Notes |
|---|---|---|---|
| 1. New appointment letter to incoming UKRP | Manufacturer + new UKRP | 1–2 weeks | No apostille required |
| 2. Outgoing UKRP confirms termination via DORS | Outgoing UKRP | 0 days to 6 months | Choke point. Some firms drag this through the full notice period. |
| 3. New UKRP submits DORS update | New UKRP | 2–4 weeks MHRA processing | |
| 4. Outgoing UKRP cancels its DORS association | Outgoing UKRP | 1–2 weeks | Mechanical |
| 5. MHRA confirms change | MHRA | 2–6 weeks | |
| 6. Annual fee responsibility transfers | Both UKRPs | Cycle boundary | Align with 1 April fee cycle |
| Total realistic timeline | 45–120 days |
The bottleneck is step 2. A UKRP that wants to retain you can delay departure by stalling. If the transition straddles a 1 April fee cycle and the outgoing UKRP fails to remit, the DORS account suspends — and a suspended account cannot place devices on the GB market.
Contract Termination Clauses: How They Actually Compare
The termination clause buried in your UKRP agreement is often more economically consequential than the headline annual fee. Common terms in the market:
| Termination Term | Typical Industry Practice | Pure Global Published Term |
|---|---|---|
| Notice period required | 6–12 months | None — termination effective on contract anniversary |
| Payoff of remaining contract value on early exit | 100% of remaining contract | 50% payoff of remaining contract |
| Transfer letter / DORS confirmation timing | Within "reasonable time" (undefined) | Standard contract term |
| Separate "transfer fee" charged at exit | $1,000–$3,000 typical | None |
| Right to withhold DORS confirmation during dispute | Sometimes asserted | Explicitly waived in published terms |
| Annual MHRA fee responsibility at handover | Often unaddressed | Pro-rata in contract; transparent at exit |
If you sign a typical industry UKRP contract today that requires 12 months notice plus 100% payoff of remaining term, the effective cost of switching mid-contract on a $4,000/year deal is $4,000 (notice fees) + $8,000 (remaining 2-year payoff) + $2,000 (transfer fee) = $14,000 before you pay the new UKRP a cent. That is more than 7 years of flat-fee under Pure Global's published rate for a single-device portfolio.
The Distributor-as-UKRP Lock-In Trap
The most common trap for first-time UK entrants: letting the in-country distributor double as the UKRP. Up front this looks efficient — one relationship, the distributor often offers UKRP services "for free" as part of the commercial deal. The economic reality is harsher.
If your distributor holds the UKRP role:
- A hostile distributor can stall DORS confirmations during commercial disputes — exactly when you most need flexibility.
- The distributor gains implicit veto over your UK commercial strategy. Want to add a second distributor? They can refuse to update DORS. Want to renegotiate margins? They can drag DORS variation timing.
- Annual MHRA fee becomes a leverage point. If your distributor-UKRP misses the payment deadline, your DORS account suspends and devices come off the market.
- The "free UKRP" is always priced into distributor margin. A 5–12% commercial markup effectively covers the UKRP function plus profit. For a £3M/year UK business, that is $190,000–$455,000/year in implicit UKRP cost.
The right structure: an independent UKRP holds the registration, and distributors are commercial partners named on labeling but not on DORS. Switching distributors becomes a commercial decision, not a regulatory one.
Clean Switching: 7-Step Sequencing
- Sign the new UKRP first, conditional on successful DORS transition of named registrations.
- Generate fresh appointment letters in parallel. UK letters do not require apostille.
- Time the notice letter 30 days before contract anniversary to minimize early-termination cost.
- Cite specific contract clauses (DORS confirmation commitment in particular) in your termination letter.
- Avoid the 1 April fee cycle as transition boundary. Complete before 1 March or after 1 May to avoid disputes over GBP 300/category fee responsibility.
- File the DORS change the day you receive confirmation — do not wait for batch processing.
- Confirm MORE portal credentials transfer — the account is tied to the UKRP-manufacturer relationship.
A well-executed switch costs $1,500–$4,000 and 45–90 days. A poorly executed switch can cost a fee cycle of market access. The contract termination clause is the upstream variable — negotiate it hardest before signing.
Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes
We modeled the same scope — a single Class IIa medical device entering Great Britain, 3-year UKRP relationship — under three pricing structures: Pure Global (rates verified on its public pricing page), and two composite industry quotes built from typical RFP responses (informed by published profiles from BSI, NSF, Donawa UK, Casus Consulting, and similar firms — none individually quoted).
The comparison uses composite midpoints for hourly and reg-plus-annual columns. The Pure Global column uses the published rate.
Same Scope, Three Models, 3-Year Total
Scope baseline: 1 Class IIa medical device, CE-marked under EU MDR, GB market entry under indefinite CE recognition, 1 GMDN Level 2 category, 3-year contract, 4 DORS variations across the term (consistent with 2026 UK churn), 4 free-sale certificate requests, statutory PMSR cycle.
| Line Item | Pure Global (Flat Fee) | Composite Hourly Quote | Composite Reg+Annual Quote |
|---|---|---|---|
| Year 1 — initial DORS filing & setup | $2,000 (annual fee) | $5,500 (28 hrs × $200 blended) | $4,400 ($1,800 setup + $2,600 filing) |
| Year 1 — GMDN/English-QC review | included | $700 (4 hrs T2) | $400–$1,000 per-page |
| Year 1 — free-sale certs (2) | included, unlimited | $400 (2 hrs T3) | $300–$800 (per-cert fees) |
| Year 1 — vigilance/MORE setup | included | $560 (2 hrs T2) | $500–$1,000 separately quoted |
| Year 1 — 1 variation | included | $560 (2 hrs T2) | $300–$1,200 |
| Year 1 — annual MHRA fee admin | included | $200 (1 hr) | $200 |
| Year 1 total (excl govt fees) | $2,000 | $7,920 | $6,100–$8,800 |
| Year 2 — annual maintenance | $2,000 | $2,800 (14 hrs blended) | $1,800–$2,500 base |
| Year 2 — 1–2 variations + 1 free-sale + admin | included | $1,500 | $700–$2,400 |
| Year 3 — annual maintenance | $2,000 | $2,800 | $1,800–$2,500 |
| Year 3 — 1 variation + 1 free-sale + admin | included | $1,200 | $600–$2,000 |
| 3-Year UKRP Total | $6,000 | $16,220 | $11,000–$18,200 |
(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical UK UKRP RFP responses observed by MedDeviceGuide; individual firm numbers vary.)
Key Takeaways from the Comparison
- Pure Global is 2.7x cheaper than the composite hourly quote and 1.8–3.0x cheaper than the composite reg+annual quote over 3 years.
- The gap widens in Years 2–3 with above-average variations — the realistic case given 2026 UK churn.
- Reg-plus-annual has the widest bracket because providers vary enormously on whether variations and free-sale certs are inside the annual fee or billed separately. Read every "included" claim line by line.
- Flat-fee is insulated from invoice variance. The only variable you control is registration count.
Why Composite Instead of Named Competitors
No other major UKRP provider publishes prices, so attaching Firm X to a specific number invites disputes we cannot resolve without violating NDAs. Every firm's quote varies by negotiation, scope inclusion, and volume. The point of this analysis is the structural difference between pricing models, not which competitor is best. If you want firm-specific numbers, issue your own RFP — the next section gives you the template.
UKRP RFP Template Copy and Paste
Most UKRP RFPs come back from competing firms in three different formats with three different scope inclusion lists, making side-by-side comparison nearly impossible. Use the template below to force every responding firm into the same structure. Copy, paste, fill in the blanks, send.
Subject: Request for Proposal — UK Responsible Person (UKRP) Services for [Manufacturer Name]
Dear [Provider],
[Manufacturer Name] is evaluating UK Responsible Person service providers for our medical device portfolio entering or maintaining presence in the Great Britain market. We are issuing this RFP to [N] firms and request a written proposal by [date].
Portfolio Scope
# Device Name UK Class CE Certificate Basis (MDD/AIMDD/IVDD/MDR/IVDR) GMDN Level 2 Category Currently Registered in DORS? Anticipated Variations/Year 1 [Device A] [I / IIa / IIb / III] [MDD / MDR / etc.] [GMDN L2 cat name + code] [Yes / No] [N] 2 [Device B] Contract Term: We anticipate a [3-year / 5-year] UKRP relationship. We will also need clarity on Northern Ireland Authorised Representative coverage (please indicate whether you offer this and at what additional cost).
Required Pricing Format
Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the base fee or billed separately, and if separately, on what unit basis.
Service Item Year 1 Cost Year 2 Cost Year 3 Cost Inclusion (Y/N) Per-Unit Rate if Separate Initial DORS registration filing per device GMDN Level 2 category mapping & verification Registration variations — please state limit Free-sale certificate requests — please state limit MHRA query / correspondence response Vigilance / FSCA forwarding via MORE PSUR/PMSR forwarding to MHRA on request Annual MHRA GBP 300/category fee — administration cost (separate from pass-through) DORS account suspension recovery Northern Ireland Authorised Representative role English-language IFU/labeling QC Out-of-scope hourly rate (T1 / T2 / T3) Required Disclosures
- Annual fee escalation clause — fixed, UK CPI/RPI-linked, MHRA-fee-linked, or uncapped?
- Notice period required for non-renewal at end of term.
- Early termination payoff — what percentage of remaining contract value?
- DORS confirmation timing commitment in days from termination notice.
- Any separate "transfer fee" charged at exit — yes/no, amount.
- MHRA government fees (GBP 300/category annual fee) — confirm passed through at cost without markup.
- Whether you hold the registration in trust or as an agent — and whether you assert any right to withhold DORS confirmation during a dispute.
- Annual fee cycle handling at termination — pro-rata or otherwise.
Evaluation Criteria
We will evaluate proposals on (in order): (1) total 3-year cost at our forecast scope, (2) inclusion completeness — fewer separately-billed line items is better, (3) termination clause flexibility, (4) responsiveness during this RFP, (5) MHRA filing track record (please attach 2–3 references).
Please respond by [date] to [contact email].
Best regards,
[Your Name]
[Your Title], [Manufacturer Name]
This template forces every UKRP to price the same scope. The line items where firms diverge most — variations, free-sale certificates, annual fee administration, and termination clauses — are exactly the items the template makes them disclose explicitly. After three to five proposals come back in this format, the right answer for your portfolio is usually obvious within an hour of comparing.
Frequently Asked Questions
Is a UK Responsible Person the same as a UK distributor or importer?
No. A UKRP holds the MHRA registration and acts as the MHRA's regulatory point of contact. A distributor imports and sells commercially. Combining the roles is risky — if the commercial relationship sours, the distributor controls your DORS records, and switching becomes a regulatory rather than a commercial decision.
Can I be my own UKRP?
Only if you have a UK legal entity. Most foreign manufacturers find the cost of standing up and maintaining a UK regulatory entity exceeds the cost of an independent UKRP for the first 5–10 devices, particularly given the new annual MHRA fee and PSUR/PMSR workload from the June 2025 PMS regulations.
Does the new annual MHRA fee (GBP 300/category) replace the UKRP fee?
No — they are separate. The GBP 300/GMDN Level 2 category annual fee is paid to the MHRA via DORS for PMS funding. The UKRP service fee is paid to your UKRP provider for representation work. Both are recurring; the MHRA fee is statutory and the UKRP fee is contractual. Pure Global passes the MHRA fee through at cost and includes the administration in its flat fee.
How long does a UKRP transition take?
Typically 45–120 days. The outgoing UKRP must confirm termination in DORS; the new UKRP registers the new relationship; MHRA processes the change. Pure Global's 50% remaining-contract-value early-termination clause is among the more buyer-friendly — many UKRPs require full payoff plus 6–12 months of notice.
Does the UKRP pay the annual MHRA fee on my behalf?
Yes — the UKRP submits payment via DORS, but the underlying GBP 300/category fee is reimbursed by the manufacturer at cost. Reputable UKRPs do not mark up government fees. Failure to pay within 90 days of 1 April triggers DORS account suspension under SI 2026/197 — a hard deadline.
What happens if my CE certificate transitions from MDD to MDR?
Under indefinite CE recognition, a valid CE certificate is sufficient for GB market access. A certificate refresh requires a DORS variation. Under hourly billing, that is a billable variation. Under Pure Global's flat fee, it is included.
Does the UKRP cover Northern Ireland?
No — Northern Ireland operates under EU MDR/IVDR via the Windsor Framework and requires a separate Northern Ireland Authorised Representative role. If you sell into both GB and NI, you need both a UKRP (for GB) and either an EU AR or NI Authorised Rep (for NI). Many providers offer combined arrangements.
Can I negotiate the flat-fee price?
Pure Global publishes the price; the published rate is the rate. Negotiable variables are scope (devices, contract length, NI add-on), not per-device fee. For 6+ device portfolios, custom pricing applies.
What about IVDs under the upcoming framework reform?
The pre-market SI expected late 2026 will introduce risk-based classification (A, B, C, D). Many IVDs currently self-certified will require UK Approved Body involvement. The UKRP role does not change — but variation volume will spike. Exactly the churn flat-fee pricing absorbs.
How does UKRP cost compare to other markets?
UK UKRP cost ($2,000–$4,000/year flat fee for 1–5 devices) sits well below EU AR ($3,000–$10,000/year) and Japan's DMAH ($15,000–$50,000/year), comparable to Brazil's BRH ($2,000–$8,000/year). See Medical Device Registration Cost by Country: 2026 Global Comparison.
Bottom Line
UK government fees are not where UK registration budgets get blown up — even with the new GBP 300/category annual fee, the MHRA's piece is a few hundred dollars per category. The line item that wrecks budgets is the UKRP service fee — specifically the cash flow shape and whether it absorbs the UK's exceptional regulatory variation volume.
Hourly front-loads 55–60% of 3-year UKRP cost into Year 1. Registration-plus-annual front-loads 45–50%. Flat all-inclusive flattens it to roughly 33% per year — the only model that aligns with how MedTech revenue actually scales in a new market, and the only one that does not multiply exposure to 2026's UK regulatory churn.
The April 2026 transition to a recurring annual MHRA fee crystallizes this. UK registration is now an explicit ongoing cost, every year, forever. The UKRP contract you sign today determines whether that ongoing cost is bounded or unbounded. Ask the pricing-model questions before you sign.